EG ·
AXIN 150MG 20CAP
AXIN 150MG 20CAP
Composition
These source-reported data require scientific review and are not treatment advice.
NIZATIDINE
· AMOUNT_PER_UNIT
Registration
Packages and prices
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| ULCFREE 150 MG 20 CAP | SAME_ACTIVE_INGREDIENT_SET | dosage_form, route | — EGP |
| nizatact 300 mg cap | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| nizatect 150 mg cap | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| NIZATINE 150MG 20/CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| AXIN 150MG 20/CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| RECEPTOLOC 300mg 20/CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| RECEPTOLOC 300mg 10/CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| NIZATECT 300MG 20 CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| NIZATINE 300MG 20/CAP | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |